![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: STK32A |
Gene summary for STK32A |
![]() |
Gene information | Species | Human | Gene symbol | STK32A | Gene ID | 202374 |
Gene name | serine/threonine kinase 32A | |
Gene Alias | YANK1 | |
Cytomap | 5q32 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | Q8WU08 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
202374 | STK32A | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 1.02e-02 | 3.76e-01 | -0.2116 |
202374 | STK32A | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 5.84e-16 | 6.29e-01 | -0.0166 |
202374 | STK32A | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 2.42e-18 | 6.27e-01 | -0.0132 |
202374 | STK32A | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 1.75e-20 | 6.14e-01 | -0.013 |
202374 | STK32A | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 1.40e-13 | 5.56e-01 | -0.0121 |
202374 | STK32A | RNA-P7T1-P7T1-1 | Human | Lung | AIS | 2.93e-09 | 9.52e-01 | -0.0961 |
202374 | STK32A | RNA-P7T1-P7T1-2 | Human | Lung | AIS | 1.01e-12 | 1.04e+00 | -0.0876 |
202374 | STK32A | RNA-P7T1-P7T1-3 | Human | Lung | AIS | 1.47e-11 | 1.05e+00 | -0.0822 |
202374 | STK32A | RNA-P7T1-P7T1-4 | Human | Lung | AIS | 7.43e-13 | 1.03e+00 | -0.0809 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00181056 | Lung | IAC | peptidyl-serine phosphorylation | 69/2061 | 315/18723 | 1.48e-08 | 1.87e-06 | 69 |
GO:00182095 | Lung | IAC | peptidyl-serine modification | 70/2061 | 338/18723 | 1.23e-07 | 1.10e-05 | 70 |
GO:001810512 | Lung | AIS | peptidyl-serine phosphorylation | 60/1849 | 315/18723 | 4.75e-07 | 3.64e-05 | 60 |
GO:001820912 | Lung | AIS | peptidyl-serine modification | 61/1849 | 338/18723 | 2.49e-06 | 1.41e-04 | 61 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
STK32A | SNV | Missense_Mutation | c.358G>A | p.Glu120Lys | p.E120K | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-C8-A275-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
STK32A | SNV | Missense_Mutation | novel | c.922G>C | p.Asp308His | p.D308H | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-C8-A3M7-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
STK32A | SNV | Missense_Mutation | rs780042168 | c.8N>T | p.Ala3Val | p.A3V | protein_coding | tolerated(0.21) | benign(0.011) | TCGA-E2-A574-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
STK32A | SNV | Missense_Mutation | rs749568069 | c.79N>G | p.Arg27Gly | p.R27G | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-E9-A1NF-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | PD | |
STK32A | SNV | Missense_Mutation | novel | c.665C>T | p.Pro222Leu | p.P222L | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
STK32A | deletion | Frame_Shift_Del | c.983delA | p.Lys328SerfsTer10 | p.K328Sfs*10 | protein_coding | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||||
STK32A | SNV | Missense_Mutation | c.940N>C | p.Glu314Gln | p.E314Q | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-A6-2685-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
STK32A | SNV | Missense_Mutation | c.83C>T | p.Ala28Val | p.A28V | protein_coding | deleterious(0) | possibly_damaging(0.708) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD | ||
STK32A | SNV | Missense_Mutation | c.586A>C | p.Lys196Gln | p.K196Q | protein_coding | tolerated(0.54) | benign(0.027) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD | ||
STK32A | SNV | Missense_Mutation | c.162G>A | p.Met54Ile | p.M54I | protein_coding | tolerated(0.08) | possibly_damaging(0.838) | TCGA-AA-3509-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |